The QualityStocks Daily Tuesday, July 31st, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (JMU) +558.85%

QualityStocks (GTXOD) +45.11%

OTCtipReporter (NAKD) +44.93%

The QualityStocks Daily Stock List

Protagenic Therapeutics, Inc. (PTIX)

OTC Markets, Zacks, InvestorPoint, Market Exclusive, Simply Wall St, Annual Reports, Wallet Investor, Stockopedia, Barchart, YCharts, GuruFocus, MarketWatch, Infront Analytics, Marketbeat, Morningstar, Stockhouse, 4-Traders, and Capital Cube reported on Protagenic Therapeutics, Inc. (PTIX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Protagenic Therapeutics, Inc. is a pre-clinical biopharmaceutical company listed on the OTC Markets Group’s OTCQB. It works to develop first-in-class neuro-active peptides into human therapeutics to treat anxiety, treatment-resistant depression, addiction, as well as other disorders. Protagenic Therapeutics has its corporate headquarters in New York, New York. Protagenic Therapeutics Canada, Inc. has its office in Stouffville, Ontario.

Protagenic Therapeutics’ mission is to provide innovative, safe and effective treatments for anxiety and depression through using neuropeptide hormones to restore normal emotionality. The Company is developing PT00114 as a therapeutic for anxiety, depression, post-traumatic stress disorder (PTSD) and addiction.

Protagenic’s focus is novel anti-anxiety and anti-depression natural brain hormone pharmaceutical agents, founded on encouraging preclinical results. It has created a portfolio of novel neuropeptides, which are in different stages of development and preclinical evaluation for the treatment of mood disorders.

Recently, Protagenic Therapeutics announced that the naturally-occurring brain peptide upon which its lead drug compound, PT00114, is based, known scientifically as teneurin C-terminal associated peptide (TCAP), was featured in three peer-reviewed publications in major scientific journals.

The three high profile publications support the potential of the Company’s Synthetic TCAP to treat stress-related psychological disorders. TCAP-1 has shown encouraging results in pre-clinical neurologic testing in anxiety and depression.

The Company states that TCAP-1 is a promising treatment for anxiety and depression as it appears to alleviate high stress response-related behaviors. Protagenic’s present work aims to actively pursue therapies, which harness the stress-diminishing capabilities of TCAP-1 in order to boost stress-response.

Regarding its PT00114, Protagenic Therapeutics’ studies have shown evidence that PT00114 is a strong regulator of cellular metabolism. This includes neuronal cells. The Company believes that because this mechanism is similar across different animal species and humans, that its experimental observations can form the foundation for Protagenic’s molecule to work by greatly improving neuronal health.

Protagenic Therapeutics, Inc. (PTIX), closed Tuesday's trading session at $1.95, even for the day. The average volume for the last 60 days is 650 and the stock's 52-week low/high is $1.25/$2.20.

chart

NanoVibronix, Inc. (NAOV)

Zacks, InvestorsHub, and MarketWatch reported on NanoVibronix, Inc. (NAOV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTC BB-listed, NanoVibronix, Inc. is a medical device company using its proprietary and patented low intensity surface acoustic wave technology. The Company’s pioneering technology allows for the creation of low-frequency ultrasound waves, which can be used for an array of medical applications, including the disruption of biofilms and bacteria colonization, and also providing pain relief. NanoVibronix has its headquarters in Elmsford, New York. The Company’s Research and Development (R&D) is in Nesher, Israel.

NanoVibronix’s products include PainShield®, UroShield™, NG-Shield™, and WoundShield™. These devices can undergo administration at home, without the aid of medical professionals. The PainShield® device is a wearable, battery powered electronic unit. It uses a disposable patch through which it delivers localized energy creating therapeutic effect to relieve localized pain and stimulate soft tissue healing.

The UroShield™ system is a multi-targeting solution. Its intention is to work against several factors, which are vital in preventing catheter related complications. The NG-Shield™ utilizes the Company’s proprietary acoustic technology onto the Nasogastric tube in such a way that it noticeably decreases the trauma and effective friction of the tube and blocks tube associated pain and discomfort.

The WoundShield™ system is a novel, patch-based therapeutic ultrasound device. It facilitates soft tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. The WoundShield™ may also be used to enhance oxygen and topical drugs delivery. In December 2016, NanoVibronix announced that it received clearance to sell the WoundShield™ in Canada.

This past March, NanoVibronix announced that it was granted a patent by the United States Patent and Trademark Office (USPTO) entitled, "System and Method for Surface Acoustic Wave Treatment of Skin," with a term through 2033, which does not include regulatory extensions.

The Company’s Surface Acoustic Wave (SAW) technology employs a portable patch-based therapeutic device to facilitate soft tissue regeneration by producing ultrasound surface acoustic waves on the skin to increase local capillary perfusion and tissue oxygenation. The surface acoustic waves extend beyond the skin contact area of the device. Therefore, this allows treatment of infected skin areas without painful contact between the device and the infected area.

Recently, NanoVibronix announced successful interim trial results for UroShield™. The trial was conducted at two skilled nursing facilities near Buffalo, New York, in which 22 subjects underwent evaluation. Mr. Brian Murphy, NanoVibronix Chief Executive Officer, said, "We are very excited to report the results of this latest study, which reinforces our earlier pre-clinical data demonstrating a significant reduction in bacterial colonization on catheter devices when using UroShield™.”

NanoVibronix, Inc. (NAOV), closed Tuesday's trading session at $4.66, up 5.69%, on 10,160 volume with 63 trades. The average volume for the last 60 days is 10,357 and the stock's 52-week low/high is $3.68/$7.32.

chart

AmeriCann, Inc. (ACAN)

Promotion Stock Secrets, TopPennyStockMovers, Cannabis Financial Network News, OTC Markets Group, SmallCapVoice, Real Pennies, and TheMicrocapNews reported earlier on AmeriCann, Inc. (ACAN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

An Agricultural Technology company, AmeriCann, Inc. is developing sustainable, state-of-the-art medical cannabis cultivation properties. The Company is a national leader of sustainable cultivation and processing infrastructure for the medical marijuana industry. It designs, builds, as well as owns efficient cultivation and processing facilities to produce medical cannabis. It is developing projects across the nation in regulated markets by way of the “Preferred Partner Program”. OTCQB-listed, AmeriCann has its headquarters in Denver, Colorado.

The Company has a multi-market growth strategy with an existing portfolio of more than 1,000,000 sq. ft. of sustainable cannabis production infrastructure in development. AmeriCann’s mission is to serve medical cannabis patients through providing facilities designed and constructed to produce high quality, consistent medicine, cultivated and processed in a controlled, secure, and sustainable environment.

The Company identifies, acquires, and develops real estate particularly suited for cannabis operations. AmeriCann finances real estate development. Additionally, it provides necessary venture capital to developing cannabis enterprises.

In May, AmeriCann announced the hiring of Dr. Brian Corr as Director of Horticultural Science and Operations. He is a 40-year veteran in the traditional horticulture industry with companies such as Ball Horticulture and Syngenta (SYT). Dr. Corr is a renowned expert in controlled-environment horticulture. He will lead AmeriCann's management services division.

In June, AmeriCann announced that it completed a very successful three-year partnership with a licensed Colorado cannabis producer, which resulted in excellent returns to the Company. AmeriCann contributed $1,000,000 in secured funding in 2014 for the final design and construction of a 15,000-square foot state-of-art cultivation and processing facility in Denver, Colorado. Its Preferred Partner, 4900 Jackson, LLC, has been a licensed medical cannabis producer in Colorado since 2010.

With the final payment made in May of 2017, AmeriCann received total distributions over the term of the agreement of $1,457,000. This was from consulting fees, interest, and principal repayment. The average yearly returns surpassed 15 percent over the 3 years.

At the end of July, AmeriCann announced strong support for the milestone adult use cannabis bill signed by Massachusetts Governor Charlie Baker on July 28, 2017. The new law implements the successful ballot measure approved by voters in November 2016. Massachusetts is the first state in the eastern United States to legalize the adult use of marijuana.

AmeriCann, Inc. (ACAN), closed Tuesday's trading session at $2.41, up 10.55%, on 208,678 volume with 350 trades. The average volume for the last 60 days is 89,645 and the stock's 52-week low/high is $1.11/$5.35.

chart

CloudCommerce, Inc. (CLWD)

Wolf of Penny Stocks, Epic Stock Picks, MoneyTV, and Investor News Source reported earlier on CloudCommerce, Inc. (CLWD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CloudCommerce, Inc. is a provider of cloud commerce services to top brands. The Company is a global provider of cloud-driven e-commerce and mobile commerce solutions. Furthermore, CloudCommerce strategically acquires profitable cloud commerce solutions providers with strong management teams. The Company’s objective is to be a full-service provider of cloud commerce solutions for medium, large, and worldwide enterprises. CloudCommerce is headquartered in Santa Barbara, California.

CloudCommerce’s services include the development of highly customized and sophisticated online stores; real-time integration to other business systems; digital marketing and data analytics; complete and secure site management; and integration to physical stores. CloudCommerce’s goal is to capitalize on the growth in technology industry subsets: Security Technology, Cloud Computing, Business Analytics, Storage, and Wireless, through acquiring strong companies in a roll-up strategy.

Through acquiring experts in e-commerce, digital marketing, and enterprise commerce solutions, Company Management is working to build an e-commerce super-competitor that lets each subsidiary operate autonomously while combining resources and sharing ideas to create cost savings and cross-marketing opportunities.

Further to development, CloudCommerce can also totally manage its customer solutions with services. These include technology consulting, continuing maintenance, hosting infrastructure build out and management.

The Company acquired Indaba Group (Denver, Colorado). Indaba is an e-commerce developer centering on the Magento platform. The acquisition of Indaba Group brings a profitable and growing operation into CloudCommerce’s operations, which meshes well with its current e-commerce development operations.

Indaba Group is a strategic e-Commerce agency. Indaba specializes in enterprise software development, e-Commerce platform development, creative services, and customer experience management

Recently, CloudCommerce announced the launch of its new digital marketing division.
The new division will provide services including Content Marketing, Marketing Automation, Social Media Strategy/Marketing, Search Marketing, Account-Based Marketing, Sales Enablement, Data Analytics, and Brand Strategy/Brand Experiences.

The Company’s intention is to expand into these areas of focus via direct sales efforts to existing clients, prospective clients and joint partnerships, and through the strategic acquisition of digital marketing services firms.

Earlier this month, CloudCommerce announced the execution of a merger agreement under which it acquired 100 percent of Parscale Creative, Inc. Parscale Creative consists of certain assets spun out of Giles-Parscale, Inc., a San Antonio-based enterprise owned by Brad Parscale and Jill Giles. After closing the transaction, Parscale Creative was renamed Parscale Digital, Inc. Parscale is a fast-growing provider of enterprise digital marketing services.

CloudCommerce, Inc. (CLWD), closed Tuesday's trading session at $0.02165, up 35.31%, on 10,000 volume with 3 trades. The average volume for the last 60 days is 31,068 and the stock's 52-week low/high is $0.0094/$0.0625.

chart

Oroplata Resources, Inc. (ORRP)

Stockhouse, Investcom, Stockopedia, Marketwired, OTC Markets, InvestorsHub, Equities, CapitalCube, SmallCap Network, and Stock of the Week reported on Oroplata Resources, Inc. (ORRP), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Oroplata Resources, Inc., by way of its subsidiaries, engages in the exploration and development of lithium and other minerals. LithiumOre Corp is a wholly-owned subsidiary of Oroplata Resources. Oroplata engages in the development of lithium brine deposits in the State of Nevada. Formed in 2011, Oroplata Resources is based in Incline Village, Nevada. The Company lists on the OTCQB.

Oroplata Resources’ LithiumOre subsidiary is a lithium resource exploration and development enterprise. LithiumOre’s principal focus is the establishment of a low-cost production base to supply the fast-developing lithium-ion battery industry for mobile devices and laptops, and the accelerating EV (electronic vehicle) industry.

The LithiumOre subsidiary currently has 5,200 acres in the region called the Western Nevada Basin in Railroad Valley in Nye County, Nevada (WNB Claim). Its claims have undergone evaluation by experts and the Bureau of Land Management (BLM) and determined that 260 claims of the WNB Claim were suitable for LithiumOre’s planned exploration.

LithiumOre announced this past April that it executed a strategic partnership with 3PL Operating, Inc. for the exploration of the Company's Western Nevada Basin lithium brine project in the Railroad Valley, Nevada. 3PL has substantial experience in drilling, development and production of oil and gas that is similar to lithium development since the metal is contained in liquid brines and produced from shallow wells.

3PL will drill on the Railroad Valley to obtain brine samples and evaluate lithium concentrations at the Western Nevada Basin project. Moreover, in April, LithiumOre announced that it identified many zones indicative of a lithium brine aquifer at its Western Nevada Basin project in Railroad Valley.

Earlier this month, Oroplata Resources’ LithiumOre subsidiary announced that it received approval from the BLM for its drilling permit. Therefore, it will be starting its drill program at the Railroad Valley lithium exploration project.

Additionally, LithiumOre announced that it has now received the necessary permitting to drill to depths of 750 meters (2500 feet). The expectation is that drilling will begin in mid-September.

Oroplata Resources, Inc. (ORRP), closed Tuesday's trading session at $0.143, up 2.14%, on 4,018 volume with 6 trades. The average volume for the last 60 days is 380,005 and the stock's 52-week low/high is $0.0575/$0.42.

chart

Lithium Exploration Group, Inc. (LEXG)

MicroCap Daily, Insider Financial, Penny Stock Tweets, Epic Stock Picks, OTC Markets, and The Wolf of Penny Stocks reported on Lithium Exploration Group, Inc. (LEXG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lithium Exploration Group, Inc. concentrates on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. The Company is currently focusing on sales and distribution of the Sonic Cavitation Ltd. technology and the acquisition of oil and gas related assets in the U.S. and Canada. An exploration and development company, Lithium Exploration is based in Phoenix, Arizona.

Lithium Exploration’s commitment is to developing assets and technologies in Oil & Gas, and Waste Treatment. The Company is developing an ultrasonic generator for different field applications in the oil and gas industry. The technology provides lower cost, low energy solutions to many pre-existing processes within these markets.

Lithium Exploration’s Oil & Gas assets consist of the White Top Field. This asset is positioned onshore in Southwest Louisiana.  The cumulative production to-date is 32 million barrels. Current production is 120 barrels of oil per day.

The Company has partnered with Sonic Cavitation (SonCav) to develop SonCav's patented technology for the treatment of hydrocarbon fluid stocks and waste water. The SonCav generator is skid mounted for easy mobility to even the most remote field locations. At present, SonCav is field ready for customers across North America. SonCav runs off of 3 phase electricity. It produces no on-site emissions.

Lithium Exploration announced this past March that its partners in the White Top project were making major progress on the preparations to close on the eventual acquisition of the field and development strategy. The seismic data has been totally processed.

Lithium Exploration stated that it continues to impress all parties that have looked at it. The Company has a royalty interest in the future development of the major oil and gas opportunity in Louisiana.

Lithium Exploration’s Blockchain efforts in the oil and gas industry are moving forward. The Company has been incubating a Blockchain concept, which will make it much easier and more transparent for investors who are not part of the oil and gas ecosystem to participate in investment opportunities.

Nonetheless, the Company is not spending any money on those efforts until after the completion of the royalty acquisition.  Lithium Exploration is looking to partner with a couple of external companies to establish the Blockchain marketplace that it will manage.

This month, Lithium Exploration announced that preparation and permitting was initiated at its oil project in SW Louisiana. The expectation is that the pad undergoing preparation will host the drilling of the first three target locations.

A joint team of internal and external geophysicists have prepared the locations.  This team has identified these locations in a specific fault block, using the processed seismic data collected last year versus historical production from the field, and determined that these locations will be the most productive. The team has put a projection of 800K to 1.4M barrels of oil from this fault block that can be simultaneously extracted by drilling three wells at different depths. 

Lithium Exploration Group, Inc. (LEXG), closed Tuesday's trading session at $0.0154, down 5.52%, on 491,602 volume with 40 trades. The average volume for the last 60 days is 324,235 and the stock's 52-week low/high is $0.0003/$0.18.

chart

Newrange Gold Corp. (NRGOF)

OTC Bulls, PennyStockHub, Barchart, Stockwatch, OTC Markets, TheProspectorNews, Junior Mining Network, Marketwired, InvestorsHub, Stockhouse, and First Look Equities reported on Newrange Gold Corp. (NRGOF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Newrange Gold Corp. concentrates on near to intermediate term production opportunities in favorable jurisdictions. This includes Nevada and Colombia. An exploration and development enterprise, the Company incorporated in 2006 as Colombian Mines Corporation, dedicated to exploring high quality mineral properties in Colombia. It diversified into the U.S. in July of 2016 through acquiring the high-grade Pamlico gold project in Nevada.

Newrange Gold is based in Vancouver, British Columbia. The Company changed its name to Newrange Gold Corp. in December of 2016. Its shares trade on the OTC Markets’ OTCQB.

Newrange Gold has its Pamlico Project in Mineral County, Nevada. In Colombia the Company has its El Dovio and Yarumalito projects.

The Pamlico Project is a high-grade epithermal gold system hosted in Jurassic to Tertiary age volcanic and sedimentary rocks. This project encompasses the historic Pamlico Mines on Pamlico Ridge, together with the Central, Sunset, and Good Hope, Gold Bar and various unnamed mines and prospects.

In Colombia, the Yarumalito Project covers a large gold dominant porphyry complex composed of manifold intrusive centers. This property covers 1,456 hectares of highly prospective terrain, eleven air kilometers north of the famed Marmato District.

Regarding the El Dovio project in Colombia, Newrange Gold holds 100 percent undivided interests in the mineral licenses, which encompass all potential mineralization at El Dovio. It purchased 100 percent of the surface rights covering the same ground at El Dovio.

The El Dovio property encompasses high-grade polymetallic gold-silver-copper-zinc mineralization in a belt of marine volcano-sedimentary rocks known to host other polymetallic and Volcanogenic Massive Sulfide (VMS) prospects and mines.

Newrange Gold announced in February 2018 that its systematic program of mapping and sampling at Pamlico identified another very prospective, high-grade gold drill target called "Tom's Hammer". Rock chip samples yielded up to 130 grams gold per tonne (g/T Au) in mineralized sedimentary rocks of the East Zone - North.

Similar work in the Pamlico Ridge Area identified high-grade gold mineralization. Together, the six high potential exploration areas at Pamlico have a combined strike length of over 14 kilometers.

Earlier in July, Newrange Gold announced that Phase III drill results extended the mineralized gold trend to about 1,600 ft (488 m) on strike to the southeast from the Merritt Decline Area along Pamlico Ridge. This latest round of drilling demonstrates a roughly 400 percent increase of prospective high-grade vein and disseminated gold targets.

The drilling expanded the strike length and width of the mineralized corridor. It also identified new host rock and structural settings favorable for hosting gold mineralization.

Newrange Gold Corp. (NRGOF), closed Tuesday's trading session at $0.10, up 5.82%, on 3,000 volume with 2 trades. The average volume for the last 60 days is 11,849 and the stock's 52-week low/high is $0.05/$0.54.

chart

Research Solutions, Inc. (RSSS)

Marketbeat.com and Wall Street Resources reported earlier on Research Solutions, Inc. (RSSS), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Research Solutions, Inc. is an innovator in providing cloud-based solutions for scientific research. The Company is a pioneer in cloud-based SaaS (Software-as-a-Service) research intelligence products and services for research-intensive organizations. Research Solutions has its wholly-owned subsidiary Reprints Desk, Inc. The Company’s cloud-based SaaS platform provides customers with on demand access to, and augmented data from, tens of millions of scientific, medical, and technical (STM) documents. This is in addition to tens of millions of articles beforehand published.  Research Solutions has its corporate headquarters in Encino, California.

Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Reprints Desk and Altmetric LLP previously agreed to integrate Altmetric badges to scholarly content obtained via Reprints Desk's award-winning research retrieval platform Article Galaxy. Altmetric is a top research metrics provider.

The Altmetric badges provide an at-a-glance visualization of the attention a particular journal article has received online from mainstream and social media, public policy documents, blogs, Wikipedia, and scholarly forums. These help scientists in assessing the reach and influence of research.

Research Solutions and its wholly-owned subsidiary Reprints Desk have launched a new version of the Company's award-winning Article Galaxy research platform. New features include full mobile responsiveness, design enhancements, an improved order history page, and the introduction of an ecosystem of gadgets - robust applications that allow for sophisticated data augmentation of content.

Reprints Desk has signed separate reseller agreements with Ritme and Alfasoft to deliver new tools and services that address the complete range of knowledge acquisition and information management requirements of researchers in scientific, technical, and also medical (STM) fields.

In May, Research Solutions reported financial results for its fiscal Q3 ended March 31, 2017. Total revenue was $8.6 million versus $8.7 million in the year-ago quarter. Platform revenue was up 124 percent to $270,920, with a 152 percent increase in total Platform deployments to 116. Annual recurring revenue was up 127 percent to $1.1 million.

Customer count was up 9 percent to 985. Transaction count was up 7 percent to 212,827. Transaction revenue was basically unchanged at $6.4 million.  Net loss was $(0.6) million, or $(0.03) per share, versus net income of $32,000 or $0.00 per share. This loss was because of Research Solutions’ continued investment in its rapidly growing, recurring revenue Platform business.

Recently, Outsell, Inc. gave Research Solutions and Reprints Desk top ratings for its recently released version of the Article Galaxy SaaS research platform. Outsell is the globe’s only research and advisory firm centered on media, information, and technology. The Outsell Insights published on April 21, 2017 concludes that Reprints Desk is delivering a considerably improved service to researchers, which provides an enhanced user experience and creates efficiencies within end-user workflows focused around app-like gadgets.

Research Solutions, Inc. (RSSS), closed Tuesday's trading session at $1.95, up 2.09%, on 205 volume with 3 trades. The average volume for the last 60 days is 8,800 and the stock's 52-week low/high is $0.662/$2.00.

chart

Spotlight Innovation, Inc. (STLT)

Penny Picks, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Beacon Equity Research, SuperStockTips, InvestorSoup, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Penny Stock Finder, Stock Preacher, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. The Company identifies and acquires rights to unique and proprietary platform technology candidates. Its emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities.

The Company’s subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. Spotlight Innovation is based in Urbandale, Iowa.

Spotlight Innovation’s mission is to considerably impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates’ is attained through its extensive relationships with numerous leading academic institutions and other sources. Spotlight provides value-added development capability and funding to expedite development progress.

The Company’s development pipeline includes product candidates for cancer, chronic pain, spinal muscular atrophy (SMA) and Zika virus infection. Spotlight works to acquire the rights, via acquisition, license, or otherwise, to innovative and proprietary Platform Technology Candidates. Additionally, it works to provide value-added development capability and funding to achieve fast IND approval to commence human clinicals for targeted Platform Technology Candidates.

Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive global rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.

Spotlight Innovation subsidiary Caretta Therapeutics has its chronic pain relief product Venodol Roll-on. This product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation.

Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. Its subsidiary, Celtic Biotech, started Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. Contract Research Organization (CRO) ImmunoClin Ltd. is supervising the study conduct.

Spotlight Innovation has entered into a multi-year partnership agreement with Hip-Hope, Inc. (Des Moines, Iowa-based), an organization committed to using arts and culture to promote, advocate and support hope for at-risk youth wherever symptoms of hopelessness are widespread.

As part of this partnership, Spotlight Innovation is the title sponsor for Hip-Hope’s 2018 “#kidslivesmatter FUNraiser Challenge” to take place August 3, 2018, at the 7 Flags Event Center in Clive, Iowa. The annual event is a youth empowerment campaign. The design of it is to build kids’ character, physical health, as well as self-esteem.

Last week, Spotlight Innovation announced that Company research collaborator Professor Kevin Hodgetts was awarded a grant of $300,000 by the nonprofit organization Cure SMA for the project Pre-Clinical Development of LDN-5178 for the Treatment of SMA.

Spotlight Innovation holds an exclusive, worldwide development and commercialization license from Indiana University Innovation and Commercialization Office for LDN-5178 and a group of related compounds. This includes STL-182.

Spotlight Innovation, Inc. (STLT), closed Tuesday's trading session at $0.0355, even for the day. The average volume for the last 60 days is 25,476 and the stock's 52-week low/high is $0.016/$0.27.

chart

Blow & Drive Interlock Corp. (BDIC)

Equities.com, MarketWatch, Bloomberg, TradingView, YCharts, News to Watch, and Reuters reported on Blow & Drive Interlock Corp. (BDIC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Blow & Drive Interlock Corp. provides automotive and criminal offender monitoring security products. The Company has its state‐of‐the‐art ignition interlock device: BDI-747. This device is approved and available in eight states for evidentiary and preliminary screening use.

In essence, the Company is an offender monitoring and police-grade alcohol detection device manufacturing and offender monitoring business. Blow & Drive Interlock has its corporate office in Los Angeles, California. The Company’s shares trade on the OTC Markets.

Interlocks are required for use by DUI or DWI (Driving Under The Influence or Driving While Intoxicated) offenders as part of their mandatory court or motor vehicle department program.

The Company’s BDI-747 is an ignition interlock device, breath-alcohol testing device about the size of a smartphone. The ignition interlock device requires the driver to exhale into the device prior to starting the vehicle. The device will prevent the vehicle from starting if the driver's blood-alcohol content exceeds a predetermined set level.

Blow & Drive Interlock states that its BDI-747 is the most advanced user friendly IID presently available. The BDI-747 can record BAC levels. It provides 2-way communication, GPS location technology, and image technology. Furthermore, the BDI-747 is wireless. 

Blow & Drive Interlock’s aim is to have the BDI-747 available to customers across the U.S. In addition, the Company continues to do research and development (R&D) of the next stage of offender monitoring. It believes this will be smartphone enabled monitoring applications (apps), which could reduce or eliminate the need for ankle bracelets or hand-held breathalyzers.

This past May, Blow & Drive Interlock announced the hiring of Mr. JC Lopez as the New Chief Operating Officer (COO) of the Company. Mr. Lopez has more than two decades of experience in the Government sector. He offers over 10 years of accomplishment-laden experience in the Interlock Industry.

Moreover, throughout his career, he has established a strong network of contacts in the interlock community that the Company states will be an extremely valuable addition to the Blow and Drive Interlock Team, boosting sales growth, market share, as well as operations efficiency.

Blow & Drive Interlock Corp. (BDIC), closed Tuesday's trading session at $0.19, up 11.76%, on 10,215 volume with 5 trades. The average volume for the last 60 days is 17,279 and the stock's 52-week low/high is $0.1501/$0.397.

chart

Black Ridge Oil & Gas, Inc. (ANFC)

TopPennyStockMovers, Amigo Bulls, Stockwatch, OTC Markets, The Street, Wall Street Resources, and Wall Street Reporting reported earlier on Black Ridge Oil & Gas, Inc. (ANFC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Black Ridge Oil & Gas, Inc. is a growth-oriented oil and gas exploration and production enterprise. The Company is focusing on non-operated Bakken and Three Forks properties. Formed in 2010, Black Ridge Oil & Gas is based in Minneapolis, Minnesota. The Company lists on the OTC Markets Group’s OTCQB.

Black Ridge Oil & Gas’ strategy has shifted from asset Owner to asset Manager. The Company focuses on its asset management business and partnering with investment sponsors to acquire oil and gas assets. In addition, it focuses on energy loans and providing capital for oil and gas drilling/completion projects.

The Company, along with its capital providers, is working to acquire oil and gas assets throughout the major United States onshore basins. Since 2010, it has participated in drilling more than 300 Bakken or Three Forks wells in North Dakota and Montana.

Black Ridge Oil & Gas currently controls greater than 10,000 net Bakken and/or Three Forks acres. The Company receives short term income from management fees from the varied joint ventures (JVs) - Black Ridge Holding Company, LLC initially; Merced Black Ridge, LLC (established July 2015), and others as it makes acquisitions.

Black Ridge Oil & Gas takes a minority rather than majority interest in its wells. This strategy produces a highly-diversified portfolio of Bakken and Three Forks wells throughout the Williston Basin for Black Ridge.

At present, Black Ridge manages Working Interests (WIs) in greater than 350 gross Bakken and/or Three Forks wells. These produce about 1,500 net BOEPD (Barrels of Oil Equivalent Per Day).

Being a non-operator, the Company participates in Bakken and Three Forks wells on a proportionate basis. This is according to its leasehold interest in each drilling unit drilled by its operating partners.

Concerning its Merced Black Ridge Partnership, Merced (formed in July of 2015) provides equity capital. This capital is used to acquire/develop non-operated assets in all U.S. onshore basins. Black Ridge sources deals and manages day to day business.

Black Ridge Oil & Gas, as sponsor of Black Ridge Acquisition Corp. (BRACU), is looking to acquire oil and gas assets across the major U.S. basins. Black Ridge Acquisition is a special purpose acquisition company (SPAC) centered on identifying a growth-oriented merger candidate.

Black Ridge Oil & Gas, Inc. (ANFC), closed Tuesday's trading session at $0.02456, up 1.49%, on 6,660 volume with 2 trades. The average volume for the last 60 days is 68,778 and the stock's 52-week low/high is $0.0122/$0.0725.

chart

BioCardia, Inc. (BCDA)

TradingView, Insider Financial, Stockopedia, Marketbeat, InvestingNote, and MarketWatch reported on BioCardia, Inc. (BCDA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioCardia, Inc. is a leader in the development of total solutions for cardiovascular regenerative therapies. The Company’s biotherapeutic product candidates in clinical development are CardiAMP® (autologous minimally processed bone marrow cells [a patient’s own cells]) and CardiALLO® (allogenic culture expanded mesenchymal stem cells derived from bone marrow [donor-derived]) cell therapies. A clinical-stage regenerative medicine company, BioCardia is based in San Carlos, California.

BioCardia’s two therapeutic programs are enabled by its Helix™ transendocardial delivery systems and Morph® vascular access products that are partnered to enable other promising biotherapeutic programs. Also, the Helix transendocardial delivery system is being used by a number of clinical partners in biotherapeutic clinical trials.

The Helix transendocardial delivery system is the leading percutaneous catheter delivery system for cardiovascular regenerative medicine. Helix enables the local delivery of cell and gene-based therapies to treat heart failure, myocardial infarction, ischemia, as well as cardiac conduction disorders.

The Company’s CardiALLO uses younger universal donor mesenchymal stem cells. BioCardia states that CardiALLO may be suitable for patients who are not optimal candidates for the CardiAMP therapy.

CardiAMP harnesses the potential of autologous minimally processed bone marrow cells, using a companion diagnostic to identify patients most likely to benefit from the therapy. The design of the investigational CardiAMP cell therapy system is to deliver a high dose of a patient’s own bone marrow cells directly to the area of cardiac dysfunction to stimulate the body’s natural healing mechanism after a heart attack.

BioCardia announced in January 2018 that the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with refractory angina (RA).

The CardiAMP Chronic Myocardial Ischemia Trial will be a prospective, multi-center, randomized, sham-controlled, patient- and evaluator-blinded pivotal trial. The trial is to validate the safety and efficacy of CardiAMP investigational cell therapy in the treatment of patients having CMI with RA.

The CardiAMP Heart Failure Trial is presently enrolling patients at 13 world class centers in the U.S. with Center for Medicare and Medicaid Services (CMS) National Reimbursement.  The trial design was published in the American Heart Journal in April of this year.

BioCardia received a new US Patent related to its CardiAMP cell potency assay. This provides further protection to the Company’s autologous cell therapy programs in heart failure and chronic myocardial ischemia indications.

On April 25, 2018, BioCardia announced the issuance of United States Patent No. 9,945,854 relating to methods of measuring therapeutic potency potential and defining dosages for autologous cell therapy.

In May, BioCardia announced that the Centers for Medicare and Medicaid Services (CMS) approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.

BioCardia, Inc. (BCDA), closed Tuesday's trading session at $1.33, down 5.00%, on 495,999 volume with 3,309 trades. The average volume for the last 60 days is 450,879 and the stock's 52-week low/high is $8.40/$23.70.

chart

Andrea Electronics Corp. (ANDR)

Stock Guru reported earlier on Andrea Electronics Corp. (ANDR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Andrea Electronics Corp. designs, develops, and manufactures audio technologies and equipment for enhancing applications necessitating high performance quality voice input. The Company is an innovator of digital audio input enhancement software, computer headsets, and array microphone technologies. In addition, it is an industry leading developer of product solutions that optimize the performance of voice user interfaces for different applications. Andrea Electronics is based in Bohemia, New York, it lists on the OTCQB.

Andrea’s patented Digital Super Directional Array (DSDA™), patented PureAudio™, and patented EchoStop™ far-field microphone technologies enhance a wide variety of audio products to eliminate background noise and ensure the optimum performance of voice applications. The Company’s products include Array Microphones, Active Noise Cancellation Microphone Headsets, USB Headsets, Headphones, Computer Microphones, USB Audio Adapters, Noise Reduction Software, and Echo Cancellation Software, which betters the performance and provides ease of use for applications.

These applications include Speech Recognition, Voice over the Internet (VoIP), Video conferencing, Game chat, and live digital audio recordings. Among the more recent advances from Andrea Electronics are SuperBeam Stereo Array Microphone headsets and the DA-250 digital microphone stand alone solution for original equipment manufacturers (OEMs).

Andrea Electronics has its Go Mic Connect, USB stereo array microphone with the Company’s audio enhancement software. This bundle is the most adaptive digital microphone on the market. The design of the Company’s latest filter libraries is for OEMs targeting new product platforms running Linux and Android operating systems. This is while using new strong mobile processors with DSP cores, including ARM.

The Andrea PC Audio Software (AudioCommander™) provides the latest Audio Commander and noise cancellation filters for use with all Andrea USB Devices. The install supports Windows.

Today, Andrea Electronics announced that it is suing Apple, Inc. for patent infringement on audio processing technology found in the defendant's products. The hearing at the U.S. International Trade Commission in Washington, DC is set to commence today, August 21, 2017.

Mr. Douglas Andrea, Chief Executive Officer of Andrea Electronics, said, "We are a proud, third-generation family business whose products are showcased in the Henry Ford Museum and the Smithsonian National Museum, and we refuse to stand by and watch a legacy built over 80 years to be torn down by electronic giants with deep pockets and global influence. We are proud that Apple, like our already existing licensees, desires the use of our technology, but we request that they license it legally. If they refuse, we ask that the ITC stop them from selling products that contain our patented technology."

Andrea Electronics Corp. (ANDR), closed Tuesday's trading session at $0.0817, up 2.13%, on 12,800 volume with 8 trades. The average volume for the last 60 days is 120,920 and the stock's 52-week low/high is $0.0379/$0.185.

chart

The QualityStocks Company Corner

GreenBox POS, LLC (OTCQB: GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC (OTCQB: GRBX) is pleased to announce that it accepted an invitation and agreed to appear in a special TV production. The special is set for broadcast on Fox Business Network in the September-October timeframe. Also today, FMW Media Works, the parent Company of “NEW TO THE STREET” and “Exploring The Block” TV shows, was pleased to also formally announce signing GreenBox.

GreenBox POS, LLC (OTCQB: GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $1.20, up 41.84%, on 209,278 volume with 146 trades. The average volume for the last 60 days is 28,396 and the stock's 52-week low/high is $0.017/$0.99.

Recent News

chart

Sharing Services, Inc. (OTC: SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services, Inc. (OTC: SHRV) (“the Company”) has filed its 10K with the Securities and Exchange Commission for the year ended April 30, 2018. The Company reported sales of $8.3 million dollars since launching its products on Dec. 13, 2017. Also today, NetworkNewsWire released a report on the company detailing how SHRV is working to address the unique challenges facing the growing number of entrepreneurs ditching the office for direct selling, due to factors such as flexibility of working hours, accessibility of technology and lower overhead.

Sharing Services, Inc. (OTC: SHRV) headquartered in Plano, Texas, is a diversified holding company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth, and sending as many successful company “families” as possible on vacation.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.32, up 17.22%, on 17,600 volume with 7 trades. The average volume for the last 60 days is 31,289 and the stock's 52-week low/high is $0.125/$1.07.

Recent News

chart

Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR)

The QualityStocks Daily Newsletter would like to spotlight Hammer Fiber Optic Holdings Corp. (HMMR).

Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR) d/b/a Hammer Communications announced today that it has renewed its Letter of Intent to acquire 1stPoint Communications, Endstream Communications and Open Data Centers.

Hammer Fiber Optic Holdings Corp. (HMMR), with headquarters in New Jersey, is a telecommunications company investing in the future of wireless technology. The company’s holdings include Hammer Fiber Optic Investments, Ltd., D/B/A Hammer Fiber, an Internet Service Provider (ISP) that offers internet, voice, video and data services in New Jersey as well as carrier services in Philadelphia and New York. Hammer Fiber serves residential and small business markets with high-capacity broadband, voice and video through direct fiber as well as its wireless fiber platform – Hammer Wireless® AIR technology.

Hammer Fiber recently completed the initial development phase of its advanced LTE fixed wireless system, which was designed and built upon its successfully deployed wireless technology suite. The expansion allows Hammer Fiber to add ultra-high capacity cellular broadband applications to its product portfolio including wholesale services such as backhaul support for cellular network operators. Designed to complement Hammer Fiber’s core business of home residential service, the company expects this latest innovation to help position Hammer Fiber as a leader in future 5G technology. The company intends to leverage the Fixed LTE system in conjunction with its already deployed Fixed Wireless DOCSIS 3.1 system to deliver on one of its core promises, to deliver high capacity broadband to markets across the country at dramatically lower cost than traditional wireline methods, including fiber. Live field testing of the new system begins in early 2018 in the U.S. with service availability to follow later in the year.

Hammer Fiber has also expanded its IaaS (Infrastructure-as-a-Service) cloud services to include support for the cryptocurrency and blockchain industry. Interested companies will be able to host their products over Hammer Fiber’s robust and modern server infrastructure, fiber network architecture and data center presence in some of the most secure locations in the New York, New Jersey and Philadelphia regions. Hammer Fiber’s servers feature best-in-class computing power, designed to allow enterprise businesses to reap the benefits of utilizing a cloud-based system without the massive cost of establishing or maintaining a corporate data center.

“Distributed architecture infrastructure, such as those utilized by blockchain entities mining cryptocurrencies or other new vertical markets utilizing blockchain technology, are growing exponentially and we are poised to fulfill a critical but fundamental need of this explosive new industry,” said Mark Stogdill, CEO of Hammer Fiber. “The distributed ledger architectures that blockchains are built on require secure and robust data processing networks, highly scalable power generation and a reliable fiber optic backbone infrastructure linking up data centers worldwide for them to exist, and that is what we at Hammer Fiber do really well.”

Hammer Fiber seeks to achieve its vision by employing an extremely qualified group of business professionals with diverse backgrounds and successful track records from a variety of related industries. HMMR’s seasoned leadership team combines startup expertise with a consummate understanding of the regional competitive telecommunications landscape in sales, marketing, engineering, construction and business development.

Hammer Fiber Optic Holdings Corp. (HMMR), closed the day's trading session at $0.71, up 12.70%, on 682,338 volume with 188 trades. The average volume for the last 60 days is 158,941 and the stock's 52-week low/high is $0.3301/$48.00.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (OTC: MCOA), an innovative hemp and cannabis corporation, and its joint venture partner Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) (the “Partners”) are pleased to provide an update on their high yielding CBD hemp farming project in Scio, Oregon (the “Project”). Also today, NetworkNewsWire released a report on the company detailing how MCOA, through wholly owned subsidiary hempSMART™, is delivering all the benefits of hemp-derived cannabidiol products amid an ongoing struggle to end the opioid epidemic. The company was also highlighted today in a report on how Hemp-CBD oil commands thousands of dollars per kilogram and cannabis and hemp growers in particular have the potential to realize more than $100,000 profit an acre growing hemp plants to produce it.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.03124, up 15.28%, on 6,799,828 volume with 318 trades. The average volume for the last 60 days is 8,003,788 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF).

Globally licensed cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its entrance into a definitive agreement to acquire 100% of the issued and outstanding share capital of Canna Farms Limited, a premium cannabis company in British Columbia. To view the full press release, visit: http://nnw.fm/gsV4P. Also today, ABCCF was highlighted in an article on the growing opportunity for hemp-based CBD products, as active cannabis companies continue to diversify product offerings and target new markets.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” ABcann Global CEO Barry Fishman said.

ABcann Global owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

ABcann has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by ABcann’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting ABcann’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

ABcann’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with ABcann’s philosophy of quality and innovation.

ABcann’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, ABcann also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

ABcann Global (ABCCF), closed the day's trading session at $0.9817, up 8.96%, on 323,328 volume with 376 trades. The average volume for the last 60 days is 215,487 and the stock's 52-week low/high is $0.65/$3.2929.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX); the "Company" or "Lexaria"), a drug delivery platform innovator, and Hill Street Beverage Company Inc., (BEER; "Hill Street") jointly announced that they have signed a Definitive Agreement to license Lexaria's DehydraTECHTM, on a semi-exclusive basis, for a term of five (5) years, to produce a line of cannabis-infused alcohol-free beverages for Canadian distribution, following regulatory approval.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.7175, up 3.46%, on 113,718 volume with 146 trades. The average volume for the last 60 days is 240,077 and the stock's 52-week low/high is $0.322/$2.54.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, announced today it has acquired certain transactional services portfolio (cash flow assets) from Universal Payment Systems (“UPS”). Also today, NETE was highlighted in new independent research reports released early this morning, as Fundamental Markets debuted its latest key findings.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $7.15, even for the day, on 62,183 volume with 343 trades. The average volume for the last 60 days is 137,472 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

Accelerated Technologies Holding Corp. (OTC: ATHC)

The QualityStocks Daily Newsletter would like to spotlight Accelerated Technologies Holding Corp. (ATHC).

Accelerated Technologies Holding Corp. (OTC: ATHC) released Q2 financials and a business update today. In the second quarter, ATHC expanded its Intelagy subsidiary (www.Intelagy.com) and launched subscription-based merchant services designed to help small- and mid-sized businesses (SMBs) alleviate payment processing fees.  Intelagy enables merchants to pay interchange and subscribe monthly for services, in most cases saving thousands of dollars annually.

Accelerated Technologies Holding Corp. (OTC: ATHC) is a full-service end-to-end business solution and technology company that specializes in cloud-based disruptive technologies. The Company provides consulting and enterprise-level technology services and is developing its own disruptive technology products in the sectors of artificial social realities, short-term alternative funding platforms, electronic payment solutions, and blockchain technologies focused on social engagement, sports, entertainment and content creation.

ATHC is more than a publicly traded company determined to make a buck. Its mission is to create a pioneering business model by taking a leadership position in institutionalizing investment in the regional venture capital market. ATHC’s core values, beliefs and fundamentals revolve around today’s great visionaries – the great leaders of tomorrow. For young entrepreneurs, ATHC offers funding assistance, guidance and investment capital in return for reasonable equity, commitment and an unparalleled work ethic. ATHC and its economies of scale enable the Company to develop technology at reasonable costs while leveraging expertise and contacts for effective execution. The Company intends to create shareholder value by monetizing equity retained by ATHC.

ATHC’s investment domain and expertise lies in consumer Internet, cloud computing and software-as-a-service (Saas), mobile software and services, software-powered consumer electronics, infrastructure and applications software, networking, storage, databases and other backend systems. ATHC’s portfolio to date includes:

  • Finbridge Holdings provides capital to alternative lenders with receivables between $2 million and $5 million and to those operating in merchant cash advance and other short-term micro loan environments. Finbridge Holdings’ lending model provides ISOs with an alternative to private placement capital to obtain cash to grow their business. Finbridge intends to be a leader in the loans-to-lender space, primarily focused on those specializing in the small to medium business lending channel.
  • XStreamCorp – a Reality Gaming Social Network. XStreamCorp presents an opportunity to penetrate popular social gaming networks by incorporating proprietary technologies that provide users with streaming video, audio and messaging capabilities. These enhancements will dramatically change the player experience in online gaming. Revenue is expected via sales of in-game virtual goods in Social Poker Play formats and events; in-game advertising; and banner advertising around the Company’s gaming portal.
  • IconXchange will endeavor to provide a decentralized, open, resilient infrastructure for a new generation of human funding that includes blockchain-based IconXchange Coins and value-based IXC tokens. IconXchange aims to be a platform through which valuable brands are identified, grown, and incentivized. A value-based token enables enhanced liquidity and accelerated funding. IconXchange intends to capitalize on the blockchain’s evolution and improvement without being locked into any one protocol or platform.

ATHC is the destination to discover professionals, guidance, cross marketing opportunities, industry trends, and investments. The Company was built with a unique and scalable approach to collect, leverage and contribute to a strong community of venture capital partners, dynamic sales and marketing verticals, and in-house data teams armed with powerful machine learning, data science, development, management and execution skills. ATHC provides corporate consulting for private and publicly traded companies; technology planning and engineering services; installation and maintenance of cybersecurity resources; and venture capital and financing.

The management team at ATHC is driven, committed, and experienced in building infrastructure for startups. President Kevin H. Kading is the founder, chairman and CEO of Kading Companies S.A. Between 1979 and 1995, he held various positions at Wall Street investment banking firms. Since 1995, he has been a member of Securities Traders Association both nationally and in New York. Kading was a founder, officer, and chairman of the Board of Advanced Reconnaissance Corp. from 1997 to February 2006.

Managing director Alex M. Lemberg has worked as a business analyst on Wall Street since 1992 with the following companies: Merrill Lynch, Morgan Stanley, Barclays Capital, CIBC, Bank of America Securities, and Credit Suisse. He brings a vast understanding of the business process and the use of technologies in order to maintain a streamlined, user-friendly environment.

Accelerated Technologies Holding Corp. (ATHC), closed the day's trading session at $0.31, even for the day. The average volume for the last 60 days is 2,200 and the stock's 52-week low/high is $0.026/$1.00.

Recent News

chart

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF).

Artificial Intelligence company, AnalytixInsight Inc. (TSX-V: ALY; OTCQB: ATIXF) announces that its wholly owned subsidiary, Euclides Technologies Inc. (“Euclides”), has joined the IFS Partner Network as a channel partner in North America. Euclides will now sell and implement IFS Field Service Management™ (FSM) and IFS Planning and Scheduling Optimization™ (PSO) software.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company’s flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube’s freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy’s largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo’s 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo’s established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners.

AnalytixInsight Inc. (ATIXF), closed the day's trading session at $0.313, even for the day. The average volume for the last 60 days is 4,191 and the stock's 52-week low/high is $0.15/$0.6898.

Recent News

chart

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42)

The QualityStocks Daily Newsletter would like to spotlight FANDOM SPORTS Media Corp. (FDMSF).

FANDOM SPORTS Media Corp. (CSE:FDM) (OTC:FDMSF) (FRANKFURT:TQ42) (“FANDOM SPORTS” or the “Company”), creator of FANDOM SPORTS, the new app that aggregates, curates and produces fan-focused content, today announced an interactive campaign called #FSBG (FANDOM SPORTS BIG GAME) to identify and reward epically passionate football fans.

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app. As an aggregator, curator and instigator of both company-created and user-generated content, the FANDOM SPORTS app is designed to entertain sports enthusiasts with real-time, interactive content on a mobile only app that offers bragging rights and real-life rewards. True sports addicts will appreciate an app that allows fans to pick a fight or create their own FanFights and rule over others as they trash talk their way to victory. The FANDOM SPORTS proprietary data centric “argument engine” measures and scores opinionated dialogue, as well as establishes consensus, giving fans and users the ability to dive deeper into one-of-a-kind cultural moments, cheer on favorite sports teams and slam dunk some sweet rewards.

Building on the company’s tag line – “Pick a Fight” – the FANDOM SPORTS app provides an always fresh, authentic rush of deeper-than-surface interactive content that resonates with the targeted age demographic of 18-34. Intense sports fans aren’t afraid of stepping up to the plate to engage other users by unleashing their opinions within the app’s structured debate resolution tool coined “FanFights.” Sports-loving fans can explore, gloat, vote, invite friends, create provocative FanFight topics and play to win while inside the FANDOM SPORTS app, which is currently available in the Apple App store and coming to the Google Play store imminently. The company’s self-learning algorithm predicts and collects user preferences while building relevant personalized FanFight channels, bringing the concept of competitive, in-your-face conversation to a whole new level of sports entertainment.

The FANDOM SPORTS app is free to play (F2P) with in-app purchase and subscription capabilities. The gaming aspect of the ecosystem is built on behavioral economics and delivers multiple revenue streams by maximizing average revenue per daily active user (ARPDAU) and user-generated content (UGC), with select placement of high-impact video and moment-based marketing as part of the brand-sponsored FanFights and in-app offers. The global platform enables applications (either FANDOM SPORTS created or 3rd party apps) to be operated in partnership with leading sports themed brands, leagues, and service providing companies within three verticals – live action, eSports, & fantasy – from around the world by supplying “interactive sports entertainment” to fans. The FANDOM SPORTS platform creates a bullet-proof snapshot of the app’s fan base through a Blockchain supported “PlayerCard” in tandem with the “Engagement Score”, which doubles as an invaluable acquisition and retention tool for its business operators. FANDOM SPORTS hosted transactions are placed on the distributed ledger, making them immutable and public to verified users interacting within the business ecosystem. Tracking this digital footprint provides extremely valuable metadata generated by users’ very dynamic behavior and sports passion.

FANDOM SPORTS’ Brand and Sponsorship partners are harnessing the affluent sports fans age 18-34 with integrated marketing content and service experience. The moments-based marketing integration will translate through FanCoin redemption, in exchange for items provided by programs established by FANDOM SPORTS and its clients. These programs are a key part of the business model and covers, as an example, the following partners; Sports Leagues, TelCo’s service offerings, and Content owners (i.e. FANDOM SPORTS provides new paying customers to the owners of pay-per-view platforms).

“Pick A Fight. Talk Trash. Get Rewarded.”

FANDOM SPORTS Media is an entertainment company that aggregates, curates and produces unique fan-focused content.

The FANDOM SPORTS App is the Company’s core product, which is the ultimate destination for unfiltered raw sports talk. The app allows passionate sports fans to unleash their primal sports passions, pick fights and earn rewards.

So download the app and bring your crew. Talking trash is better with friends. The more you invite, the more FanCoins you earn.

You may also visit the Company’s website at www.fandomsportsmedia.com or contact them directly at info@fandomsportsmedia.com.

DISCLAIMER:

The CSE has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors and uncertainties, many of which are beyond the Company’s control. Some of these risks and uncertainties may be described in the Company’s corporate filings (posted at www.sedar.com).

The Company has no intention or obligation to update or revise any forward-looking statements due to new information or events

FANDOM SPORTS Media Corp. (FDMSF), closed the day's trading session at $0.06529, even for the day. The average volume for the last 60 days is 10,512 and the stock's 52-week low/high is $0.0601/$0.2864.

Recent News

chart

Global Payout, Inc. (OTC: GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout Inc. (OTCPink:GOHE) ("Global") is pleased to welcome Stormy Simon as Strategy Officer and member of the Company's Board. Stormy spent 15 years with the E-Commerce pioneer Overstock.com through the early stages of their development and helped them to emerge as a nationally recognized e-commerce leader. As a result, she brings a wealth of experience in the arena of startups and new industry creation and we are excited to welcome her to the MTrac Team.

Global Payout, Inc. (OTC: GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.011, off by 5.17%, on 4,213,012 volume with 108 trades. The average volume for the last 60 days is 3,988,168 and the stock's 52-week low/high is $0.0099/$0.16.

Recent News

chart

Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8)

The QualityStocks Daily Newsletter would like to spotlight Victory Square Technologies Inc. (VSQTF).

Subject to all requisite regulatory approvals, Victory Square Technologies Inc. (CSE: VST, OTC: VSQTF, FWB: 6F6) announced it intends to convert an aggregate of $805,240.47, the majority of which comprises loans advanced to the Company by Shafin Diamond Tejani, Chief Executive Officer of Victory Square, into common shares in the capital of the Company (the “Shares”). Each Share would be issued at a deemed value of $1.00 per Share. As the current market price is $0.84 per Share, the deemed value represents a premium of 19% per Share.

Victory Square Technologies Inc. (VSQTF) is a venture builder that creates, funds and empowers entrepreneurs working in the fields of blockchain technology, virtual reality, artificial intelligence, personalized health, gaming and film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources, and other forms of operational support to help them scale internationally.

Victory Square has made multiple early partnerships and investments in the blockchain space. Approximately three years ago the company incubated and invested in BTL Group, which is now a $150 million dollar TSX-listed company offering blockchain solutions across multiple industries with particular focus on the finance, energy and gaming sectors. BTL’s showcase product – Interbit – is a blockchain platform that facilitates the rapid development of business applications that dramatically improve efficiency. Some of the world’s largest institutions are using Interbit to explore new opportunities on private blockchains.

A new social sports betting platform to be developed by Victory Square’s wholly owned subsidiary, FansUnite Media Inc. As a social sports data platform, FansUnite relies on robust data to allow members of its community to engage with like-minded individuals by collaborating, discussing, and predicting the winners of sporting events with a free virtual currency. The integration of blockchain technology into FansUnite’s social sports data platform could also lead to blockchain initiatives developed by other divisions and subsidiaries of Victory Square.

Integral to the FansUnite platform is the introduction of FAN Tokens, an in-game currency purchased with the cryptocurrency Ethereum that token holders can use to place wagers. FansUnite members will be able to earn FAN Tokens through participation in any number of networking effects identified in the company’s Bounty program.

“Blockchain technology and the inherent security it provides will enable us to push every envelope we can to build the most dynamic and responsive social sports betting platform,” said Darius Eghdami, Co-Founder and Chief Executive Officer of FansUnite. “The opportunity to secure data through Blockchain certainly appeals to the accountant in me and we are confident it will become the gold standard among sports betting sites around the world.”

Company subsidiary Victory Square Health Inc., which serves as the venture arm dedicated to companies focused on the development of solutions in personalized health technologies, has also invested in Personalized Biomarkers Inc. (PBI). PBI develops test kits that reliably predict the expected response to a number of therapies prior to prescription, with an initial focus on diabetes. Within this field, five potential biomarkers have been identified, allowing PBI to enter a $4 billion market opportunity.

“We are excited for the opportunity to partner with Personalized Biomarkers as they have correctly identified a massive market opportunity, and have formed an exceptional team of industry leaders,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “This is another investment that is fully aligned with our newly created subsidiary, and one we expect to significantly impact the landscape of personalized medicine.”

A partnership with Insight Diagnostics Inc., also through Victory Square Health, will focus on the development of a personalized diagnostic solution for the improved management and prevention of Type II diabetes.

The company’s investment in V2 Games, a development and publishing studio of high-quality mobile games, is another example of incubating great ideas. V2 Games is well known for its successful launch of PAC-MAN Bounce and Beast Brawlers, two of the company’s releases that are capturing the gaming world by the millions of downloads.

In a move designed to strengthen its presence in film and entertainment, Victory Square has acquired a 40 percent equity stake in United Film Fund II, LLC, which is producing three major motion pictures in 2017 and 2018 including “What They Had,” starring two-time Academy Award winner Hilary Swank.

“This kind of investment in entertainment and film represents a major plank for our Company going forward and we consider ourselves fortunate to have the opportunity to acquire this 40% stake in the Film Fund,” said Tejani, who has launched more than 40 startups in 21 countries that employ hundreds of people and generate more than $100 million in annual revenues. “We believe it’s another strong initiative in film production for us and our stakeholders,” he added.

Victory Square has strategically positioned itself in the legal cannabis industry through an investment in Tantalus Labs, a Canadian-based cannabis cultivation company. Tantalus Labs optimizes plant health and sustainable cultivation by using a unique, environmentally controlled greenhouse engineered specifically for growing cannabis. Called a “SunLab,” the greenhouse takes 90 percent less electricity, uses filtered rainwater, and cools the growing environment to prevent stagnant moisture, recycling the air every 7 minutes to achieve maximum airflow.

Victory Square and its leadership team have seamlessly transitioned from its former identity as Fantasy 6 Sports Inc, a company focused solely on fantasy sports, mobile gaming and immersive sports, to a strategic technology company that creates, funds and successfully executes leading-edge ideas. A long-time technology entrepreneur and advocate of the industry, Tejani received the Person-of-the-Year Award at the 2017 Technology Impact Awards in British Columbia, a hallmark award category that recognizes betterment of the tech industry through leadership and philanthropic or enterprise skills and talents. Tejani has pledged to match up to $1 million in donated funds to be shared by a number of Canadian endeavors aimed at education and child-safe projects.

“These are exciting and important steps in the evolution and growth of our Company, and which properly and fully align with our strategic plan focusing on our core competencies in Blockchain Technology, Artificial Intelligence, Gaming, Personalized Health, Film and Virtual, Augmented and Mixed Reality,” said Tejani. “We’re spurred on by the success we have had in building on our original forays into fantasy sports, mobile gaming and immersive sports. In addition, we are energized by our most recent initiatives in sports, personalized health and entertainment and the confidence being shown by our shareholders in the dynamic direction of the Company.”

Victory Square Technologies and its management team believe innovation, incubation of excellent ideas and social responsibility are at the core of its growing success.

Victory Square Technologies Inc. (VSQTF), closed the day's trading session at $0.61, off by 4.82%, on 16,538 volume with 11 trades. The average volume for the last 60 days is 22,685 and the stock's 52-week low/high is $0.298/$3.32.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide an update on its three phase, scorpion venom-derived peptide research and development program (the "Program"), which consists of identifying, extracting and sequencing peptides and proteins isolated from Caribbean Blue Scorpion venom, which are a highly complex mixture of peptides, enzymes, mucoproteins, free amino acids, lipids and other biological substances.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.027625, off by 1.34%, on 658,920 volume with 54 trades. The average volume for the last 60 days is 570,448 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.